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Abstract
In 2019, the World Health Organization (WHO) named “Vaccine Hesitancy” one of the
top 10 threats to global health. Shortly afterward, the COVID-19 pandemic emerged as
the world’s predominant health concern. COVID-19 vaccines of several types have been
developed, tested, and partially deployed with remarkable speed; vaccines are now the
primary control measure and hope for a return to normalcy. However, hesitancy concerning these vaccines, along with resistance to masking and other control measures,
remains a substantial obstacle. The previous waves of vaccine hesitancy that led to the
WHO threat designation, together with recent COVID-19 experience, provide a window for viewing new forms of social amplification of risk (SAR). Not surprisingly,
vaccines provide fertile ground for questions, anxieties, concerns, and rumors. These
appear in new globalized hyperconnected communications landscapes and in the context of complex human (social, economic, and political) systems that exhibit evolving
concerns about vaccines and authorities. We look at drivers, impacts, and implications
for vaccine initiatives in several recent historical examples and in the current efforts
with COVID-19 vaccination. Findings and insights were drawn from the Vaccine Confidence Project’s decade long monitoring of media and social media and its related
research efforts. The trends in vaccine confidence and resistance have implications for
updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms
from intentional and unintentional vaccine scares.
KEYWORDS
social amplification, systemic risk, trust, vaccine hesitancy

1

INTRODUCTION

In 2019, the World Health Organization named “Vaccine
Hesitancy” as one of the top 10 threats to global health
(World Health Organization [WHO], 2019a). Shortly afterward, the COVID-19 pandemic emerged as the world’s predominant health concern, the disease, less than 2 years later,
has sickened over 280 million people around the world, and
caused over 5.4 million deaths (Kaiser Family Foundation
[KFF], 2022). Vaccines of several types have been developed
and tested with remarkable speed and are now the primary
control measure and hope for a return to normalcy. However, hesitancy concerning these vaccines, along with resistance to masking and other control measures, is a substantial
obstacle.
The social amplification of risk framework (SARF) was
developed more than 30 years ago (Kasperson et al., 1988;

Pidgeon et al., 2003). It was motivated by empirical observations in many settings that reported: (1) there were substantial differences between expert and lay perceptions of the
nature and/or seriousness of a risk, (2) such differences can
have substantial impacts on behaviors that can amplify or mitigate the risk, and (3) the perceptions and consequent behaviors may have spill-over effects on other risks as well. SARF
was put forward not as a theory but as a conceptual framework intended to guide and integrate various investigations
into how perceptions may be influenced, change, and affect
behavior, and how behavioral change leads to potential risk
consequences. The current state of vaccine hesitancy falls
squarely within the SARF: public perceptions vary widely,
with much divergence from mainstream expert perceptions:
there has been significant resistance to vaccine uptake and the
result has been higher risks of infection, as well as economic
and social risks.
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Vaccine hesitancy is not new, nor is it always unjustified. The original smallpox vaccination campaigns in the
1800s already evoked controversy—particularly with the
introduction of a vaccination mandate (Wolfe & Sharp, 2002).
In the more than two centuries since, vaccines have assumed
a major role in the management of infectious disease (Greenwood, 2014) alongside other public health measures that
reduce transmission such as public water and sewage and
drugs such as antibiotics that treat diseases. More recently,
there has been a proliferation of new vaccines (Piot et al.,
2019). In 1974, the World Health Organization launched an
initiative called the “Expanded Program of Immunization”
(EPI) to expand the reach of six basic vaccines—against diphtheria, whooping cough, tetanus, measles, poliomyelitis, and
tuberculosis—to reach children around the world (Keja et al.,
1988). From just under 5% of the world’s children getting
the six EPI vaccines in 1974, with the investment and efforts
of the EPI initiative, global immunization rates of vaccines
increased to 86% by 2010 (Peck et al., 2019). Today, vaccines against more than 25 infectious diseases are internationally recommended (WHO, 2021a), and many more are
in trial or in development. Smallpox was eradicated by 1980
(Freund, 2020; Tognotti, 2010), and while the campaign to
eradicate polio has been challenged by residual reservoirs of
wild polio virus together with recent difficulties and lapses in
vaccination efforts (Tomori, 2018), the global effort has made
tremendous progress (Matlin et al., 2017): the Global Polio
Eradication Initiative (GPEI) has certified global eradication
of wild poliovirus serotypes 2 and 3, and serotype 1 wild
poliovirus transmission now remains only in Afghanistan and
Pakistan. (Chumakov et al., 2021; Thompson, 2021; Thompson & Kalkowska, 2020; Thompson & Kalkowska, 2021;
WHO, 2021b). With these advances, immunization has been
lauded as one of the biggest public health successes, saving 2–3 million lives a year without counting the contribution of COVID-19 vaccines (United Nations Children’s Fund
[UNICEF], 2021).
Increased reliance on vaccines has been accompanied by
increased hesitancy, with outbreaks of vaccine scares and
refusals around the world. Some hesitancy concerning vaccine use is to be expected as no vaccine provides perfect
immunity and there is always a risk of some side effects,
albeit rarely serious. However, as we describe later, the phenomenon of vaccine hesitancy took a new turn with concerns about the now debunked claim by Wakefield in 1998
that the Measles, Mumps, Rubella (MMR) vaccine could be
linked to autism in children (Taylor et al., 2014), and an even
more widespread amplification of perceived vaccine risks has
occurred during the COVID-19 pandemic. Both have been
fueled by the context of a fast-changing digital environment:
social media platforms with their algorithms facilitate the
rapid spread of information, but also rumors and misinformation 2013, and importantly, these new platforms allow
for groups to self-organize around shared beliefs across the
world. While these features of information sharing and online
meeting and group formation can be an asset, these platforms
are also subject to abuse as they can be used to sell dubi-
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ous products and intentionally undermine public trust and
polarize the sentiments and political leanings of publics (Kata
et al., 2013; Broniatowski et al., 2018; Jamison et al., 2020;
Greenslade, 2013; Kennedy, 2019; Wikipedia, 2021).
While the MMR experience, experience with other vaccines, and the current experience with COVID-19 vaccine
hesitancy exhibit clearly the linkages within the SARF, these
experiences also reveal aspects of SARF that were not anticipated or fully developed in its initial formulation. The most
prominent missing aspect is the transformed nature of communication through social media, its speed, its global reach,
its interactive character, and its internal, algorithm-driven
dynamics. More attention is also needed (1) to tendencies
toward increased politicization and polarization both in communication channels and as a component of perceptions; and
(2) to the upstream context in which communications take
place and perceptions are formed. The original formulation of
SARF and the applications that have followed tended primarily to look downstream at the interpretation and consequences
of an event. We do not in this paper attempt a comprehensive update of the SARF; however, we have noted some relevant observations from vaccine experiences and have made
some adjustments in our use of the framework to accommodate these.
Our approach in this paper is to use a suitably adjusted
SARF as an organizing framework for characterizing and
interpreting the complex experiences of vaccine hesitancy
concerning a number of vaccines including the current struggles with COVID-19. We draw lessons of three sorts: lessons
from the historical experience with several vaccines that may
help with current efforts at managing COVID-19; insights
from the COVID-19 experience that may help in future efforts
to improve the use of vaccines; lessons from both sets of
experiences about needed improvements in the SARF to
make it more responsive to contemporary risk challenges.
Our paper is organized as follows: in the next section we
consider how the SARF may be applied to vaccine hesitancy.
We follow by using the SARF in describing several historical examples of vaccine scares and hesitancy with data and
interpretation largely derived from the work of the Vaccine
Confidence Project (VCP) 2020. In doing so we note key
aspects that were not prominent in the original formulation
of the SARF. Based on the observations of vaccine experiences including a section describing some of the challenges
with COVID-19, we suggest updates to the SARF that make
it more suitable for characterizing current social amplification phenomena. We conclude with some recommendations
for further development of the SARF and for its practical use
in addressing vaccine hesitancy.

2
SARF: ITS APPLICATION TO
VACCINE HESITANCY
The SARF was introduced (Kasperson et al., 1988; Pidgeon, Kasperson, & Slovic, 2003) as a response to a plethora
of observations which collectively showed that purely
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technical risk assessments did not take into account people’s experience of risk, nor did they have sufficient predictive capability to assess how risks might change over
time in response to risk management efforts and the public response. The key observations were: (1) individual perceptions of a particular risk can vary considerably and can
diverge quite sharply from the empirically based risk assessment by experts; (2) relevant perceptions include perceptions
about the likelihood and magnitude of potential harm, perceptions about attributes of the risk, familiarity, dread, people’s
sense of control, etc., and indirect associations including trust
in institutions, stigma, people’s sense of identity, and political
concerns; (3) perceptions often change with time and circumstance; (4) perceptions are strongly influenced by communications about the particular risk, and also by communication
about news and events that are seen as related to the risk; (5)
perceptions will influence behavioral responses whose consequences may affect the risk people experience; (6) people’s
behavioral response may also create ripple effects that extend
to impacts on other risks.
A further observation was that the preceding list emerged
from a fragmented social science scene with the observations presented from differing disciplinary viewpoints. The
framework was not put forward or intended as an explanatory theory. Rather it was intended as a conceptual framework
that could be used to organize and integrate the wide variety of research findings on perceptions, on communications,
and, importantly, the dynamics of their interactions. Practical
implications for risks and for risk management were also a
primary concern in the creation of the framework though it
was considered too early to provide specific applications.
In its simplest form, the framework identifies three stages
for analysis:
Stage 1: A risk-related event or other news item relating to
a risk is communicated and transformed through communication channels; the communication is further transformed as
it is interpreted by an individual or organization and interpretation may alter individual or organizational perceptions.
Stage 2: The individual’s or organization’s altered perceptions of risk influence their behavior.
Stage 3: Individual or organizational behavior will affect
risk experiences; there may be direct impacts on the risk associated with the initiating event; there may also be secondary
and tertiary impacts on other risks.
Feedback: The framework also anticipates feedback: thus,
behavioral responses may influence further communications
as communicators react to their audience and attempt to
encourage or discourage particular behaviors.
Some care should be taken in applying the framework’s
analogy of an amplifier. In an acoustic system, an amplifier
processes a signal: it may make it louder (amplification); it
may make it softer (attenuation); or it may change the mixture
of frequencies (distortion) including the possibility of adding
new sounds. If we consider the initial event or news item as
a signal, it will be potentially subject to each of these kinds
of transformation as it passes through communication channels. But this only characterizes a portion of the relevant pro-
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cesses. An interpretation which leads to altered perceptions
by an individual or organization of that transformed signal
can also be considered an amplification process: so we may
speak of the amplification, attenuation, or distortion of risk
perceptions. Or we can consider the impacts of individual or
organizational behavior: so, for instance, attenuated risk perceptions may lead to careless behavior that amplifies the risk.
Three complications of the simple version were in the
original framework and are worth noting: (1) multiple entities (individuals or organizations) may be engaged in each
stage (in keeping with the acoustic analogy, the original paper
called them “stations”); 2) more than one step may be needed
to describe the processes that form a particular stage; 3) in
particular in considering the secondary and tertiary impacts
in stage 3, these may be initiated by further communications.
When applying SARF to vaccine hesitancy, multiple risks
must be considered in parallel: the risk of the diseases which
the vaccine aims to prevent; the risks of the vaccine, and the
contextual risks, such as the launch of Google in 1998. The
framework can then be applied to both in a straightforward
manner. The initial appearance of the Wakefield report linking the MMR vaccine with autism can serve as an illustration
of such an application:
Stage 1: Triggering event: a research article is published in
Lancet (Wakefield et al., 1998), suggesting a link between the
MMR vaccine to the development of autism: stories followed
in various news media, popular magazines, tv shows, professional journals, and official recommendations: these describe
in various ways the study, the vaccine, its expected efficacy,
the possible side effects, with particular focus on the possibility of autism, the nature of autism and what is known and
not known, the prevalence and nature of measles, mumps, and
rubella, and the trustworthiness of information about entities
recommending the vaccine; multiple conversations occurred
among individuals and groups in an effort to interpret this
barrage of information; perceptions form about the risks of
the vaccine and perceptions of the risk of the disease are
adjusted; and perceptions on various related issues, including
other vaccines and the institutions that manufacture, regulate,
and recommend vaccines are reconsidered.
Stage 2: Based on their recently formed perceptions, individuals choose to respond by following or not following recommendations to have their children vaccinated. They may
also choose to engage in further communication about the
possible issues or even to join groups concerned to promote
or debunk the claims. Feedback from these responses may
encourage further communication about the study. Institutions consider whether to respond with further studies or with
recommendations to the public.
Stage 3: The choices to vaccinate or not directly affect
the risks that the children experience from the diseases the
vaccine aimed to prevent. Other choices may be about other
health decisions—for example due to loss of trust—and provoke risks of other types.
Feedback: Parents who already had anxieties about autism
as well as some parents with autistic children embraced the
findings as it gave an explanation for the seemingly growing
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FIGURE 1

LARSON ET AL.

Application of social amplification of risk framework to consequences following Wakefield’s MMR paper

phenomena of autism. Some organized groups and individuals communicated messages against the MMR vaccine, while
others joined campaigns to debunk the proposed autism link
and promote the MMR vaccine. Health institutions responded
with their own communication efforts; these were intensified
as further studies contradicted Wakefield’s and his article was
retracted by Lancet (Taylor et al., 2014).
This example is illustrated in Figure 1. Of course, a more
thorough analysis would require filling in considerable detail
for each stage. For instance, public health professionals have
identified three important factors that influence vaccine hesitancy (WHO, 2014): (i) level of confidence in the vaccines
and the vaccine administrators, (ii) complacency about the
disease, and (iii) level of convenience, that is, how difficult it
is to get vaccination. Some health researchers have extended
the list to five influences: see, for instance, Betsch et al.
(2018).

3
THE VACCINE CONFIDENCE
PROJECT™
Polarization, mistrust, and disinformation were growing long
before the COVID-19 pandemic emerged, but these societal
dysfunctions have grown more prevalent and more prominent since the pandemic began in early 2020. The VCP was
founded in 2010 to establish a systematic approach to monitoring public confidence in vaccines through populationbased surveys and ongoing media-surveillance, mapping the
global spread of vaccine sentiment, and conducting in-depth
analyses of vaccine confidence issues and their impacts (2020
Hou et al., 2020, 2021; Zhou et al., 2021). A data-driven
system was set up for early detection of public concerns
about vaccines and with which the VCP collects data and
applies a diagnostic tool to determine the risk level as to
whether those concerns could disrupt vaccine programmes
and uptake. Further, in 2015, the VCP launched a Vaccine

Confidence Index™ (VCI) (Larson et al., 2016, 2018), based
on a select number of factors identified through extensive
analysis of areas of both low and high vaccine coverage and
has surveyed over 300,000 individuals, some over multiple
waves, revealing a variety of trends and other signals (de
Figueiredo et al., 2020). In addition to in-depth qualitative
research, the VCI investigates four dimensions of vaccine
confidence: confidence in the importance, the safety, and the
effectiveness of vaccines and confidence that vaccination is
compatible with one’s religious beliefs (Larson et al., 2016).
The VCP’s compilation is the most comprehensive collection of information available on vaccine hesitancy. Much
of the data and findings that we describe in the following
sections were gathered through the VCP’s media and social
media monitoring, VCI™ surveys, and local in-depth qualitative research on drivers of vaccine resistance.

4
VACCINE EXPERIENCES
EXHIBITING SOCIAL AMPLIFICATION
OF RISK
4.1

The MMR experience

The quintessential example of social amplification of risk in
the context of vaccines is the perception that the MMR vaccine can cause autism, sparked and fueled by a publication
by Andrew Wakefield (Wakefield et al., 1998). Although his
article was published over two decades ago and was retracted
by the journal, Lancet, in 2010 (Lancet Editors, 2010) and
although many research reports before and after the retraction
have countered Wakefield’s findings (Taylor et al., 2014), perceptions that MMR caused autism have persisted and spread
globally. These perceptions reduced MMR vaccine acceptance leading to increased measles cases and measles-related
deaths; they also created distrust in medical establishments
and other vaccines.
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Figure 1 shown earlier describes how the original SARF
can be used to synthesize information about impacts of the
Wakefield report. The initial claim served as a potent triggering event. A number of reasons contributed to its powerful
impacts on perceptions and behavior. One reason lies in the
SARF stage 1 movement from interpretation to changed perceptions. The messages were heard by sensitized listeners,
especially parents who were already questioning what could
be causing autism. There was considerable uncertainty about
why there seem to be higher numbers of children developing symptoms now characterized as being an autism spectrum disorder (ASD). With no clear scientific explanation,
although more evidence is pointing to some cases having
genetic links, “MMR causes autism” appeared a plausible
explanation to the many parents eager to find a reason for
why their child developed autism. Early signs of autism usually manifest around the same time that children usually get
their MMR vaccines and the timing seemed to explain the
link, rather than to just be seen as coincidental. At the time,
there was considerable skepticism and controversy about the
claim, but that controversy also drew attention to it.
Another reason for the impact was that not all communication came through traditional reports of scientific and medical
findings. One of the biggest amplifiers of the “vaccines cause
autism” meme was that Andrew Wakefield’s paper came out
the same year that Google opened their doors, followed in the
coming years by Facebook, Twitter, and multiple other social
media platforms. Since Wakefield’s publication, hundreds of
highly organized groups have taken on a vaccine critical
stance or fully devoted their website and networks to what
has been termed “anti-vax” narratives. Johnson et al. analyze over 100 million Facebook users to study their pro- and
anti-vaccine sentiments and found that, while the numbers
expressing clearly anti-views were fewer than the pro-views,
with 50 million individuals in the middle being “undecided,”
the anti-groups were recruiting the undecided individuals at a
rate much faster than the pro-groups, with some anti-vaccine
groups growing 300% in size, compared to between 50–100%
growth on the pro-vaccine side (Johnson et al., 2020). The
amplification enabled with these social media platforms went
beyond what Wakefield could have imagined, allowing his
meme, among others, to travel algorithmically through social
networks of concerned parents seeking an answer to explain
their child’s autism or other vaccine-related concerns. These
groups and channels kept the Wakefield claims alive long
after their debunking and retraction (Larson, 2020). Figure 2
shows the global reach of news mentions almost two decades
later. A further reason for the persistence of the MMR vaccine fears, is that unlike many scientists who might have
moved on and accepted that their hypothesis might not have
been correct after multiple other studies disproved their findings, Wakefield instead started a campaign to make his case
that he was right. He turned to the many parents who had
believed and responded to him; encouraged by their feedback
he started a movement, which has since become globally connected. Neither did he stop with his initial paper, he amplified
his message through popular media. He wrote a book for the

popular press, made a movie, and turned a bus into a campaign van which traveled long distances showing the movie
and gathering testimonies to support his theory.
The consequence of these factors captured in Stage 1, are
reflected in stage 2 of the SARF. In the UK where Wakefield had his start, MMR vaccine uptake rates dropped from
92% in 1998 to 79% in 2003 (Ellman & Bedford, 2007). The
loss of confidence in vaccines led, stage 3 of the SARF, to
rising measles rates; there was also increased questioning of
vaccines and distrust of medical providers (Motta & Stecula, 2021). The impacts after the first few years became more
intense and the pathways for impact were intricate and persistent.
In recent years the impacts, stage 3 direct and indirect,
have been large: the changes in behavior, fewer people having their children vaccinated with MMR vaccine, contributed
to a surge in measles cases globally. WHO estimated that
in, 2018, there were 9,769,400 estimated measles cases and
142,300 deaths around the world, despite the availability of a
safe and effective vaccine to prevent measles (United Nations
[UN] News, 2019). In addition to the usual vaccine access
issues, particularly in conflict and migrant populations, the
other problem now was that not everyone wanted it.
The consequences were not limited to measles, mumps,
and rubella, the diseases which the MMR vaccine targets.
Concerns about vaccines spread from MMR to other vaccines
and to a loss of confidence in medical authorities which meant
that not everyone who needed medical treatment sought it
(WHO, 2019b).

4.2

The HPV experience

Vaccines against human papillomavirus virus (HPV) were
introduced in the United States in 2006 (Markowitz et al.,
2016). The history of acceptance and resistance over the following decade provides another view on the features of social
amplification of risk. These include the important role of
social media and rapid communications, the significance of
local contexts, and the potential for political influence.
The issues surrounding HPV are significantly different
from other childhood and adolescent vaccines. The viruses
are transmitted through sexual contact: sexual activity, especially of minors, raises a host of cultural-specific and religionspecific concerns among parents and in their social settings
(Ferrer et al., 2014; Madhivanan et al., 2016, Siu et al., 2019;
Wong et al., 2020); HPV is the major cause of cervical cancer in women, so the potential consequences of disease differ between men and women, thus complicating assessments
of benefits of vaccination for men and women. Furthermore,
since transmission does not occur during normal school activity, school mandates must have other justifications. All of
these issues have been prominent in shaping perceptions, and
in parental decisions about vaccinations for their children.
In this context, many healthcare providers have been reluctant to actively encourage parents to vaccinate their children
for HPV. Overall, HPV uptake has been significantly lower
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F I G U R E 2 Number and reach of on-line news articles between 2016–2017 mentioning Andrew Wakefield’s, 1998 research published in the United
Kingdom [Credit: W. Schulz, The Vaccine Confidence Project™]

than for other childhood and adolescent vaccines and significantly lower for boys than girls. Improved vaccination rates,
if obtainable, could lead to substantial numbers of lives saved
as well as reduced rates of illness (Simms et al., 2020).
Another remarkable phenomenon has been the emergence of emotional contagion and anxieties around the HPV
vaccine—from Japan to Denmark, Ireland, and Colombia—
where girls experienced a range of symptoms including fainting, para-paralysis, mobility problems, eating problems, and
chronic pain; these led to significant declines in HPV vaccine uptake in some settings. These reactions were different from the parental concerns mentioned above; these reactions were immediate—sometimes dramatically displayed—
which some of the girls were capturing on video and sharing across YouTube and other social media platforms. While
the symptoms were very tangible, most were assessed as
being psychosomatic or what the World Health Organization
now characterize as “immunization stress-related responses”
(WHO, 2019c).
In 2013, in Japan, a mix of symptoms—fainting, twitching, mobility issues, chronic pain, following HPV vaccination provoked anxiety and anger among the parents. They
organized a highly active “Victims” group on social media,
causing widespread panic and paralyzing the government,
who suspended their pro-active recommendation of HPV vaccination (Simms et al., 2020). Despite investigations finding no link between the vaccine and the symptoms and the
reaction characterized as mass psychosomatic illness (MPI),
now named as immunization stress-related responses, it is
only now, 8 years later, that the Japanese Ministry of Health,
Labor, and Welfare, is preparing to resume the active recommendation of the vaccines (Iwanaga, 2021). Modeling has
since found that the suspension, and the consequent drop in
vaccine uptake because of the amplification of risk, are likely

to result in an additional 24,600−27,300 cervical cancer cases
and 5,000−5,700 deaths that could have been averted if the
proactive recommendation of the HPV vaccine had not been
suspended (Simms et al., 2020).
These HPV vaccine reactions spread well beyond Japan
to Denmark, the Netherlands, and Ireland. There, vaccine
uptake also plummeted; however, rapid response by government agencies meant that the decline lasted only a few years.
Significantly, neighboring countries, where the reactions did
not occur showed only a small effect. The reactions spread
as far as Colombia—where over 500 girls across multiple
schools had similar reactions of dizziness, fainting, twitching
and pseudo-paralysis (Simas et al., 2019), all in the course
of 1 year. In Colombia, too, vaccine acceptance dropped dramatically. Before the 2014 mass fainting in Colombia, HPV
vaccine acceptance was as high as 98% for the first dose and
88% for the second dose, but by 2016 HPV vaccine uptake
dropped to 14% for the first dose and 5% for additional
dose. As MPI expert Robert Bartholomew notes, “We may
be witnessing a milestone in the history of MPI where the
primary agent of spread will be the Internet and social media
networks (Bartholomew et al., 2012).”

4.3

The Ebola vaccine experience

Vaccine trials often function as initiating events for social
amplification. Different experiences of changed perceptions
and changed behaviors, individual and institutional, show
clearly the importance of the context in which a trial is placed.
Clinical trials by nature have uncertain outcomes, including
risks. But the Ebola vaccine trials in the context of the 2014–
2016 Ebola outbreaks in West Africa were a particularly
heightened time of real as well as amplified risks. While some
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denied that Ebola was even real, others feared the highly fatal
virus. Some families hid sick family members, afraid that
they would be taken away to treatment centers, never to come
out again.
Some of the vaccine trials proceeded well, particularly
those which invested in extensive community engagement
and clear public messaging around the trials (Enria et al.,
2016), thus demonstrating the merits of that sort of engagement. Other trial attempts had more challenges and were disrupted by rumors and panic. The story of two Ebola vaccine
trials suspended in Ghana are a poignant example of how a
contagion of fear and risk perception can have significant and
damaging consequences. The rumor that an Ebola vaccine
trial had started, even though that was not the case, spread
like wildfire in the public as well as in political and scientific
circles and the media. The public was outraged as to why
an Ebola vaccine trial would be conducted in their country
where there had been no Ebola cases. The outrage was more
about the process—perceived as secret and untransparent—
than whether or not either trial had even started. The two trials that were under discussion, not yet approved and neither
started, were abruptly suspended by the Parliament (Kummervold et al., 2017).

5
SOCIAL AMPLIFICATION OF RISKS
IN THE CONTEXT OF THE COVID-19
EPIDEMIC

4.4

5.1

The dengue vaccine experience

In 2016, the Philippines was one of the first countries—
alongside Brazil—that introduced a new vaccine to prevent
dengue, named Dengvaxia. The Philippines and Brazil have
among the highest rates of dengue illness and death in the
world, especially among children. In 2016 alone, the Philippines had over 100,000 dengue cases and over 400 deaths
(Relief Web, 2016) and great hopes were pinned on the new
vaccine. But, 1 year after introducing the new vaccine and
immunizing over 800,000 school children, the vaccine manufacturer announced that a new risk had been identified. For
those not previously exposed to the dengue virus, the vaccine
was found to have a risk of causing more serious dengue illness in those vaccinated (Sanofi, 2017).
In Brazil, the authorities amended the instructions as to
who should get the vaccine, still approved as safe and effective for those who had been exposed to dengue. In the Philippines, the reaction was dramatically different. The vaccine
had been launched by the previous president in the height
of a national political campaign, and the news was seized
upon as an opportunity to undermine the previous government. One of the key tactics was an aggressive and highly
emotional campaign creating public panic around the safety
and risks of the vaccine; the new dengue vaccine program
was suspended, and there was a dramatic drop in public confidence in the vaccine as well as in the health authorities. The
plummeting of vaccine confidence in the broader system contributed to declines in the uptake of other vaccines, such as
against measles, as well as impacting the acceptance of other
health interventions delivered by the health authorities such
as deworming medicine in the schools (Larson et al., 2019;

Lasco & Larson, 2020). The Philippine response to the news
of the dengue vaccine risks is a special example of political
considerations over-riding public health analysis. Unlike the
HPV and Ebola experiences in which government agencies
and local politicians reacted to public concerns, in this case,
a national leader used vaccine concerns in pursuit of a particular political agenda. Several further such examples have
appeared during the COVID-19 pandemic.

The WHO declared COVID-19 a global pandemic on March
11, 2020; as of the end of December 2021, 280 million
COVID-19 cases and 5.4 million deaths have been reported
globally (KFF, 2022). However, the risk perceptions of
COVID-19 disease and its vaccines still have a striking divergence within and between experts and lay opinions, leading
to contrasting behavioral and policy responses, ripple effects,
and subsequent psychological and socioeconomical impacts
at individual and societal levels.

Perceptions and attitudes

Denialism of presence of disease was observed during
the 2014–2016 West Africa Ebola outbreaks (WHO, 2015;
Brantly, 2014; National Public radio (NPR), 2014; National
Research Council (NRC), 2016), and again during the current
COVID-19 pandemic where individuals and groups claimed
the reports of disease outbreaks or pandemics were exaggerated or even false (Miller, 2020; Klepper, 2021). Individuals
minimized the severity of COVID-19 and/or underestimated
the likelihood of contracting it, either because no one around
them had been affected, or because those who contracted the
disease did not present severe symptoms. Such denialism has
inevitably led to suboptimal support and compliance with disease containment and control measures, which include social
distancing, masking, testing, and vaccination (Hollingsworth,
2021).
Conspiracy theorists have also undermined vaccine acceptance, promoting the idea that the COVID-19 pandemic is
some kind of hoax (BBC, 2021; Thistle, 2021) or a plotted scheme by authorities and pharmaceutical companies for
political or financial gains.
In a nationally representative survey of Americans, 19%
believed that gaining immunity through contracting the disease is better than vaccination (Stecula et al., 2020). This
claim found some scientific support in a large Israeli study
(Gazit et al., 2022), which showed people who once had
a COVID-19 infection were less likely than never-infected,
vaccinated people to contract the Delta variant, develop
symptoms from it, or become hospitalized with serious
COVID-19 symptoms. In fact, however, data from the same
study suggested that previously infected people should still
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receive at least one dose of the mRNA vaccine as it provides
a much higher protection against reinfection than remaining
unvaccinated for those who once had the virus.
Furthermore, data have suggested that there have been relatively few deaths and mild disease in children under the age
of 18 years compared to other age groups. The lower likelihood of death, in combination with reports of side effects
from receiving the vaccine, has led some physicians (Makary,
2021) and parents to be on the fence about getting their
school-age children and teens vaccinated.
The catastrophic impact of the COVID-19 pandemic has
contributed to the unprecedented speed of COVID-19 vaccine
development. Effective vaccine development usually takes
almost 10 years, but several COVID-19 vaccines have been
developed and approved for use within a 1-year timeframe.
The novelty of the COVID-19 disease as well as the accelerated development and review process of COVID-19 vaccines
may have further exacerbated public concerns and heightened
risk perception regarding vaccine safety and effectiveness.
Furthermore, the introduction of a new vaccine
technology—the mRNA vaccines—during the COVID-19
pandemic has raised concerns about the ability of vaccines
to alter the DNA or genetic make-up of humans, and thus
contributed to uncertainty around the immediate and longterm adverse reactions or effects of these vaccines. On the
other hand, reports of blood clots caused by AstraZenecaOxford and Johnson & Johnson vaccines, both of which
adopted more traditional vaccine technology, have triggered
new waves of vaccine hesitancy across the globe. Governments have suspended the use of these vaccines, temporarily
or permanently as public pressure mounted, resulting in a
significant blow to Europe’s already lagging inoculation
drive despite a lack of clear evidence that the vaccine had
caused any harm.
Delta and then Omicron, were the most-infectious coronavirus variants to emerge. Mounting evidence has demonstrated that people with Delta or Omicron induced breakthrough infections also may be capable of transmitting the
virus, according to a large UK study (Pouwels et al., 2021).
Evidence of waning antibody levels have prompted calls to
offer a booster dose of a COVID-19 vaccine in countries like
Israel and the United States, while simultaneously causing
some to lose confidence in the effectiveness of vaccines available in protecting against COVID-19.

5.2
Contextual factors: Politics and public
reactions
It appears increasingly clear that review and approval, distribution, suspension, and booster offering of vaccines have
as much to do with politics as science. Negative experiences with healthcare service provision and immunization
programs in the past have been linked to distrust in health
authorities and governments and have also been identified as
driver of COVID-19 vaccine hesitancy. Some believe that the
scientific data and information about vaccines published by
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governments are misleading and unreliable, while others hold
the opinion that there has been a lack of transparency in vaccine procurement processes (Goodman & Carmichael, 2020;
Islam et al., 2021; Thacker, 2021).
Recent surveys have shown that trust in governments and
COVID-19 vaccines among healthcare professionals (HCPs)
is low in many countries. While HCPs are widely considered the most trusted source of information on vaccinerelated topics, studies have shown that some HCPs are reporting their own hesitancy around certain vaccines, influencing
their intention to vaccinate themselves as well as influencing their recommendations to their patients and target population (Luo et al., 2021; Maltezou et al., 2021; Shekhar
et al., 2021; Razzaghi et al., 2021). In Germany (Aertzeblatt, 2020), half of surveyed nurses and a quarter of surveyed doctors did not want to be vaccinated, citing fears of
side effects and long-term damage. In a five-country survey in
West Africa only 31% of respondents said they trusted their
governments enough to take the vaccine (Seydou, 2021). In a
Thailand hospital, one-fifth of physicians surveyed were not
willing to recommend the vaccine to their family members or
patients despite expressing willingness to receive a COVID19 vaccine themselves (Sirikalyanpaiboon et al., 2021). In
the United States, a survey by the Kaiser Family Foundation (KFF), a health think-tank, found that 29% of US healthcare workers would probably or definitely not get a vaccine
(Hamel et al., 2020). This lack of confidence in vaccination
among HCPs and their possible refusal of vaccination could
pose important challenges in controlling the spread of the
virus, especially among those with close and regular contact with COVID-19 patients. Their hesitancy could also create controversies and weaken public confidence in vaccination. For example, in Italy 13 cases of doctors sharing antivaccination content or playing down the severity of the virus
are currently being investigated (Solomon et al., 2021).
In the era of the COVID-19 pandemic, vaccine politicization has reached new levels of intensity. The surveys led by
the Kaiser Family Foundation have consistently found partisanship to be one of the main factors driving differences in
COVID-19 vaccination rates across the United States where
Democrats are much more likely to report having been vaccinated than Republicans, and Republicans are much more
likely to say that they definitely do not want to get vaccinated (Kates et al., 2021). Not surprisingly, such divisions
are consistent with the resistance to the adoption of other
containment measures such as face covering and social distancing, that had been introduced before the COVID-19 vaccines became available. The controversies around COVID19 vaccines have been amplified by the broader controversies
around the COVID-19 disease itself. Some political leaders,
too, have played a role in creating and sustaining polarized
views.
Possibilities for creating or countering a vaccine mandate have appeared as potent triggering events in the social
amplification, driving COVID-19 vaccine hesitancy as illustrated in Figure 3 in section 6. Although partly aligned with
political identity, the debate over the fairness of demanding

15396924, 2022, 7, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/risa.13942 by Clark University, Wiley Online Library on [09/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

1416

vaccination passports or vaccine mandates raises difficult ethical questions about how to balance public welfare against
individual liberty. Is the emphasis on risks to the public or
should people be able to decide whether or not to be vaccinated without the fear of losing jobs, being denied entry,
or facing other socioeconomical consequences? Some view
vaccination passports as completely unethical or inequitable,
or as a part of a government agenda to place citizens under
illegal surveillance and manipulate society (Medical Ethics
Advisor, 2021). Some argue that the concept of a mandate
is unethical because it will inevitably further widen societal
divisions between groups and/or because it presents a risk
of profiling certain groups based on individual’s membership in a racial, religious, or social group that has lower rates
of vaccination (Jecker, 2021). The heated discussion about
the potential violation of liberty is happening in many countries. In the United Kingdom, 34% of respondents in a survey
of 2000 adults expressed concern that vaccination passports
would be a breach of human rights, as they could discriminate
against groups who are waiting for, delaying, not wanting, or
ineligible for the vaccine, though the remaining two-thirds
support the idea despite legal and ethical concerns (Hearn,
2021).

5.3

Communication

Misinformation through social media platforms has been
identified as a key driver of COVID-19 vaccine hesitancy
(Gabarron et al., 2021; Himelein-Wachowiak et al., 2021).
Inaccurate perceptions of the risks presented by COVID19 diseases and vaccines have been further amplified on
mass and social media platforms, often through the circulation of myths, misinformation, fake news, and rumors. If
not promptly addressed, such misinformation can reverse the
gains made in combating the COVID-19 pandemic. Uncertainty, a lack of complete information, and infodemic (too
much information) around the disease and vaccines have presented an environment in which myths, misinformation, fake
news, and rumors can brew and proliferate. Misinformation
can create a public sentiment of doubt and hesitancy about
accepting vaccines. Unfortunately, some of the public figures,
health officials, scientists, or researchers who disagree with
scientific evidence about COVID-19 disease and the vaccines
have also contributed to the creation and dissemination of
misinformation and false claims around COVID-19 disease
and vaccines, and they have attracted a widespread following. Opponents of vaccine passports have been using social
media platforms to drive resistance to vaccination.
In a recent WHO technical consultation on responding to
the infodemic (and misinformation) related to the COVID-19
pandemic, experts called for swift, regular, systematic, and
coordinated action from multiple sectors of society and government (Tangcharoensathien et al., 2020); they recognized
that promoting trusted information and countering misinformation about COVID-19 vaccines is as crucial as providing
vaccines to saving lives.

What is often overlooked in the focus on misinformation
and rumors, and the role of technology platforms in their
spread, is the new opportunities for those sharing common
beliefs and perceptions to self-organize online and recruit
others to join their echo chambers.

6
DISCUSSION: UPDATING THE
SOCIAL AMPLIFICATION OF RISK
FRAMEWORK
As we described above, Figure 1 works well for describing
the few years immediately following the Wakefield report.
However, the subsequent persistence of resistance to MMR
and the broad influence this resistance has had for other vaccines require attention to other considerations.
The original proposers of the SARF did not, and perhaps
could not, anticipate the powerful role digital social media
would play in social amplification. Social media have special features for influencing perceptions: they circulate news,
rumors, and opinions very rapidly; they are interactive which
can enhance engagement; they facilitate closed circles of
information processing with mutual reinforcement. There is
much still to learn about how social media function in the
various processes described in the SARF; the prominent role
that social media have played in public perceptions of vaccines is a fertile opportunity for study.
The original authors did observe that various events and
messages could acquire symbolic meanings and that these
could influence amplification processes; they also observed
that politics and political symbolism could be significant contributors to social amplification processes. However, they did
not anticipate the recent extreme levels of political polarization around the world, nor did they anticipate how political identity could dominate other considerations in perceptions and behavior relating to health risks. While it is easy
to deplore the “politicization” of what many believe should
be nonpolitical choices, it is more difficult, but potentially
more useful to better understand such “politicization” and to
understand its implications for how individuals and institutions make choices. The debates about public health measures
for controlling the COVID-19 pandemic, including debates
about COVID-19 vaccines, have exposed many complexities in people’s ideas about individual liberty and group welfare; these complexities also appeared in earlier debates about
other vaccines, and they are different in different countries
and cultures.
The challenges in coping with risks in complex systems
were only partially addressed in the formulation of the SARF.
The SARF was an early and significant contribution to understanding systemic risks: it emphasized ripple effects, ways in
which risks can be linked to and influence each other; it also
drew attention to the importance of human connections, that
communication, perceptions, and behavioral response were
powerful links among risks. However, the original SARF perspective was primarily expansive, looking downstream from
an initiating event. An event could serve as a signal like a rock
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FIGURE 3
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Updated social amplification of risk framework for vaccination

dropping into a pool. The ripples travel outward from direct
to secondary and tertiary impacts. The challenge, posed at
that time to the risk community, was to learn how such signals get transmitted and interpreted under different conditions
in different settings. The further challenge was to consider
the implications of the resulting signals. Users of the framework have devoted considerable attention to issues of trust
and legitimacy (Kasperson et al., 2003). The SARF has also
been used to gain insight into the phenomenon of stigmatization (Kasperson et al., 2001; Flynn et al., 2001; Kasperson et al., 2003). Trust, legitimacy, and stigmatization are all
critical concerns for vaccine hesitancy (Larson & Haymann,
2010; Larson et al., 2012 ).
However, today’s situation with the MMR legacy and its
impact on other vaccines is even more complex. Still using
the ripple analogy, you can imagine instead of a pristine pool
with neat borders, a swampy pond with tree stumps and fallen
branches and some rocks and muddy islands. Ripples will
travel complex paths and create reflected ripples. But that is
not the only shift your imagination should make: we rarely
deal only with single events and their ripple pathways; other
events creating other ripple patterns, will occur in the swamp
at roughly the same time, and the ripples that we will see will
be from the interacting patterns (Schweizer et al., 2021).
The implications of such a mental shift are significant.
Already established conditions will strongly affect what happens after a triggering event. The influence of a new rumor
will depend on the surrounding circumstances and the nature
of previous rumors and responses. Just as significant will
be the degree of trust in health authorities and other relevant institutions. Proactive gathering of information on these
conditions and, when appropriate, proactive engagement with
vulnerable communities are critical capabilities for an effective response.

We illustrate the use of an augmented SARF by considering reactions to vaccine mandates. We continue to consider
three stages for analysis, but we also explicitly identify a need
for analysis of the context in which events, communications,
perceptual and behavioral changes occur. In the three stages
we give prominence to social media and the networks created
within them. Because vaccine mandates can evoke considerations of political authority and personal liberty, political
polarization will also feature in the analyses.
Stage 1: Triggering event: a vaccine mandate or new piece
of research is promulgated or disputed: comments about
health implications, peoples’ liberties, their duty to others,
and political authority surge on twitter, Facebook, and other
social media; stories about people’s reactions and legal and
political arguments appear in newspapers and on tv; people
form perceptions within their social and political networks
or on their own. Perceptions can have many aspects: some
will focus on vaccines and the disease—from perceptions that
vaccines are foreign substances with unknown effects or that
they are unnecessary, to confidence that they are safe and well
understood, that they are life-saving, that they can end other
harms the disease causes. Other perceptions will focus on the
role of the state and its institutions and on employers: what
are the limits of authority; who is trustworthy? Some perceptions will focus on mandates and their implications: will I
feel safer if those around are vaccinated? Do I fear losing my
job? Some perceptions will be about other people’s perceptions: will people follow the mandate? Will there be protests
or boycotts? Should there be concerns about other efforts at
controlling disease?
Stage 2: Changed perceptions may change individual
behavior: will previously unvaccinated people become vaccinated? Will they develop greater resistance? Will people try to influence others in their networks, or protest, or
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initiate legal action? Will other vaccination efforts be
affected? Institutional behavior may change as well: mandates may be changed or canceled, or new mandates may be
introduced; communication efforts may be altered.
Stage 3: Altered decisions to vaccinate will alter risks.
Altered mandates and communications may alter decisions
and lead to further changes in risk. Spillover effects may
occur in other vaccine situations and other vaccine-controlled
diseases. Such spillovers may involve new communications
that further alter behaviors.
Feedback: Individual and organizational behavioral
responses may influence further communications as communicators react to the responses of their audience and attempt
to encourage or discourage vaccine acceptance. Influences
may propagate broadly and very rapidly through social media
facilitated by media algorithms
Context: What has been the recent history with health care
policy and response to the disease? To other diseases? How
has the rollout of various vaccines proceeded? Is there a
legacy of controversy? Are there active anti-vaccine efforts
already underway? To what extent are various institutions
trusted? How completely are social groups and their communication channels separated from each other? What is the
political environment? What religious attitudes are prominent? What is the economic and social environment? What
populations are particularly vulnerable or have limited access
to health care?
This example is illustrated in Figure 3. As with Figure 1, a
complete analysis would fill in considerable detail.

7
RECOMMENDATIONS AND
CONCLUSIONS
It is fair to conclude from the examples we have presented,
both recent and old, and from the associated analysis, that
as vaccine hesitancy has increased, the study of vaccine hesitancy is entering a new and more mature stage. The social
amplification of risk framework can still provide needed guidance, but the framework must be revisited to be responsive
to new conditions. Two critical aspects that require deeper
study are: (1) the complex characteristics and dynamics of the
digital landscape through which much communication now
occurs, and (2) the characteristics of the complex social systems that form the context in which information and misinformation about vaccines influence vulnerability to hesitancy
or rejection of these and other medical interventions. A better understanding of approaches to reduce potentially harmful
hesitancy is emerging. However, a critical aspect which needs
more attention is to bring in more risk assessment and anticipatory measures in place of reactive responses devoted to
debunking misinformation rather than addressing the fertile
ground which fuels its spread.
In its original formulation little attention was given to how
SARF could have practical application to risk assessment and
risk management beyond its use in risk characterization. That
was a reasonable choice at the time, since there was little
actual experience using the SARF. Thirty some years later,
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however, considerable experience has accumulated; the vaccine and recent COVID-19 experience show that there is a
great need for SARF applications that can help in mitigating
some of the undesirable consequences associated with social
amplification.
The SARF, in an updated configuration, should offer guidance in developing four critical aspects of a robust approach
to alleviate harmful hesitancy:
1. Identify and characterize deep pockets of harmful misinformation or efforts to undermine public trust with a view
toward developing effective interventions to build confidence in science.
2. Develop better approaches and messages that can be
deployed more quickly in response to potentially harmful
messaging.
3. Identify appropriate efforts that will enhance capabilities of communicative and interpretive processes to create
resilience against the amplification of harmful messaging
and influencing.
4. Develop better diagnostic capabilities for identifying locations, population groups, and situations that are vulnerable
to harm with the goal of finding approaches to reduce such
vulnerability.
Vaccine hesitancy is a still growing phenomenon. It is
a prime example of the social amplification of risk, and it
points to the need to further develop the social amplification of risk framework. The digital revolution has profoundly
altered communication and the development of new forms
of social networks and their influence; the framework must
take better account of these new dimensions and their role in
the amplification of risk. The dramatic change in the landscape has brought into prominence the systemic nature of the
realms in which social amplification occurs. It is not sufficient to consider how messages and perceptions can be amplified, suppressed, or distorted in isolation: a complex context
is almost always salient and other concerns and messages will
be important considerations in identifying potential vulnerabilities. For the social amplification of risk framework to better inform risk management and risk governance, attention to
uncertainty and to changes in context will be aids to adaptive approaches; again, a critical aspect will be achieving an
appropriate balance between proactive and reactive efforts.
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